{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:19:45Z","timestamp":1790961585273,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>MicroRNAs (miRNAs) are short regulatory RNAs that can be released in extracellular vesicles and, under pathological conditions such as autoimmunity, activate innate immune cells through Toll-like receptor (TLR) 7 and 8. This mechanism may sustain chronic inflammation. Psoriasis is an immune-mediated skin disease where the role and activation pathways of Natural Killer (NK) cells remain incompletely understood. We investigated whether miRNAs upregulated in psoriatic lesions contribute to NK cell activation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A pool of psoriasis-associated miRNAs (pso-miR) was generated and used to stimulate either purified NK cells or peripheral blood mononuclear cells (PBMCs). NK cell activation was assessed in terms of cytokine secretion and target cell killing. Inhibitor experiments were performed to demonstrate TLR activation by pso-miR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Pso-miR did not directly activate NK cells, which lack TLR7\/8, but triggered NK effector functions, including IFN-\u03b3 secretion and cytotoxicity, within PBMCs, indicating the involvement of accessory cells. Mechanistically, pso-miR engaged TLR7\/8-expressing plasmacytoid dendritic cells and monocytes, leading to the secretion of IFN-\u03b1, IL-12, and IL-18. These cytokines, in turn, drove full NK cell activation. We also identified a previously overlooked subset of CD56\n                      <jats:sup>dim<\/jats:sup>\n                      NK cells in psoriatic skin, representing mature cytotoxic NKs. Moreover, pso-miR stimulation of PBMCs induced IFN-\u03b3-producing CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, further amplifying tissue-damaging responses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Altogether, these findings reveal that psoriatic miRNAs activate an innate immune loop, which indirectly drives NK cell and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell effector functions via TLR7\/8-dependent cytokine signalling, representing a novel pathogenic mechanism of psoriatic inflammation and keratinocyte damage. Of note, such miRNA-mediated crosstalk is abrogated by the dual TLR7\/8 antagonist Enpatoran, highlighting a therapeutic avenue for modulating immune activation in psoriasis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-07909-5","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:05:32Z","timestamp":1772445932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psoriatic microRNAs induce NK cell activation via an innate immune crosstalk abrogated by the Toll-like receptor 7\/8 antagonist Enpatoran"],"prefix":"10.1186","volume":"24","author":[{"given":"Carolina","family":"Gaudenzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lo Cigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Giongrandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Zini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Schioppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tiberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Gariglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gismondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Sozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Del Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Bazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6276-5365","authenticated-orcid":false,"given":"Daniela","family":"Bosisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"7909_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"7909_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12967-016-0893-x","volume":"14","author":"LF Gulyaeva","year":"2016","unstructured":"Gulyaeva LF, Kushlinskiy NE. Regulatory mechanisms of microRNA expression. J Transl Med. 2016;14:143.","journal-title":"J Transl Med"},{"key":"7909_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A, Sj\u00f6strand M, Lee JJ, L\u00f6tvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654\u201359.","journal-title":"Nat Cell Biol"},{"key":"7909_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fgene.2013.00119","volume":"4","author":"A Turchinovich","year":"2013","unstructured":"Turchinovich A, Samatov TR, Tonevitsky AG, Burwinkel B. Circulating miRnas: cell-cell communication function? Front Genet. 2013;4:119.","journal-title":"Front Genet"},{"key":"7909_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tcb.2011.12.001","volume":"22","author":"X Chen","year":"2012","unstructured":"Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 2012;22:125\u201332.","journal-title":"Trends Cell Biol"},{"key":"7909_CR6","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303:1526\u201329.","journal-title":"Science"},{"key":"7909_CR7","doi-asserted-by":"crossref","unstructured":"Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA. 2012;109:E2110\u20132116.","DOI":"10.1073\/pnas.1209414109"},{"key":"7909_CR8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nn.3113","volume":"15","author":"SM Lehmann","year":"2012","unstructured":"Lehmann SM, Kr\u00fcger C, Park B, Derkow K, Rosenberger K, Baumgart J, et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci. 2012;15:827\u201335.","journal-title":"Nat. Neurosci"},{"key":"7909_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/41131","volume":"388","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394\u201397.","journal-title":"Nature"},{"key":"7909_CR10","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1111\/j.1582-4934.2010.01127.x","volume":"14","author":"L Yu","year":"2010","unstructured":"Yu L, Wang L, Chen S. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med. 2010;14:2592\u2013603.","journal-title":"J Cell Mol Med"},{"key":"7909_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.sbi.2017.05.010","volume":"47","author":"T Shimizu","year":"2017","unstructured":"Shimizu T. Structural insights into ligand recognition and regulation of nucleic acid-sensing Toll-like receptors. Curr Opin Struct Biol. 2017;47:52\u201359.","journal-title":"Curr Opin Struct Biol"},{"key":"7909_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.immuni.2016.09.011","volume":"45","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Ohto U, Shibata T, Krayukhina E, Taoka M, Yamauchi Y, et al. Structural analysis reveals that Toll-like receptor 7 is a dual receptor for Guanosine and single-stranded RNA. Immunity. 2016;45:737\u201348.","journal-title":"Immunity"},{"key":"7909_CR13","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1016\/j.celrep.2018.11.081","volume":"25","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Ohto U, Shibata T, Taoka M, Yamauchi Y, Sato R, et al. Structural analyses of Toll-like receptor 7 reveal detailed RNA sequence specificity and recognition mechanism of agonistic ligands. Cell Rep. 2018;25:3371\u201381.e 3375.","journal-title":"Cell Rep"},{"key":"7909_CR14","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1093616","volume":"303","author":"SS Diebold","year":"2004","unstructured":"Diebold SS, Kaisho T, Hemmi H, Akira S, Reis, Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303:1529\u201331.","journal-title":"Science"},{"key":"7909_CR15","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.4049\/jimmunol.180.6.3729","volume":"180","author":"A Forsbach","year":"2008","unstructured":"Forsbach A, Nemorin JG, Montino C, M\u00fcller C, Samulowitz U, Vicari AP, et al. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J Immunol. 2008;180:3729\u201338.","journal-title":"J Immunol"},{"key":"7909_CR16","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1002\/eji.200636617","volume":"36","author":"SS Diebold","year":"2006","unstructured":"Diebold SS, Massacrier C, Akira S, Paturel C, Morel Y. Reis e Sousa C: nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur J Immunol. 2006;36:3256\u201367.","journal-title":"Eur J Immunol"},{"key":"7909_CR17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4049\/jimmunol.174.3.1259","volume":"174","author":"KB Gorden","year":"2005","unstructured":"Gorden KB, Gorski KS, Gibson SJ, Kedl RM, Kieper WC, Qiu X, et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol. 2005;174:1259\u201368.","journal-title":"J Immunol"},{"key":"7909_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","volume":"25","author":"SR Christensen","year":"2006","unstructured":"Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006;25:417\u201328.","journal-title":"Immunity"},{"key":"7909_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.immuni.2006.07.014","volume":"25","author":"R Berland","year":"2006","unstructured":"Berland R, Fernandez L, Kari E, Han JH, Lomakin I, Akira S, et al. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity. 2006;25:429\u201340.","journal-title":"Immunity"},{"key":"7909_CR20","doi-asserted-by":"crossref","unstructured":"Farrugia M, Baron B. The role of Toll-like receptors in autoimmune diseases through failure of the self-recognition mechanism. Int J Inflam. 2017;8391230.","DOI":"10.1155\/2017\/8391230"},{"key":"7909_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaut.2017.07.012","volume":"85","author":"S Sozzani","year":"2017","unstructured":"Sozzani S, Del Prete A, Bosisio D. Dendritic cell recruitment and activation in autoimmunity. J Autoimmun. 2017;85:126\u201340.","journal-title":"J Autoimmun"},{"key":"7909_CR22","doi-asserted-by":"crossref","unstructured":"Salvi V, Gianello V, Busatto S, Bergese P, Andreoli L, D\u2019Oro U, et al. Exosome-delivered microRNAs promote IFN-\u03b1 secretion by human plasmacytoid DCs via TLR7. JCI Insight. 2018;3.","DOI":"10.1172\/jci.insight.98204"},{"key":"7909_CR23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12964-024-01924-z","volume":"22","author":"V Salvi","year":"2024","unstructured":"Salvi V, Gaudenzi C, Mariotti B, Giongrandi G, Alacqua S, Gianello V, et al. Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity. Cell Commun Signal. 2024;22:536.","journal-title":"Cell Commun Signal"},{"key":"7909_CR24","doi-asserted-by":"publisher","first-page":"578335","DOI":"10.3389\/fgene.2020.578335","volume":"11","author":"S Bosch","year":"2020","unstructured":"Bosch S, Young NA, Mignot G, Bach JM. Epigenetic mechanisms in immune disease: the significance of Toll-like receptor-Binding extracellular vesicle-encapsulated microRNA. Front Genet. 2020;11:578335.","journal-title":"Front Genet"},{"key":"7909_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2019.03.021","volume":"452","author":"D Bosisio","year":"2019","unstructured":"Bosisio D, Gianello V, Salvi V, Sozzani S. Extracellular miRnas as activators of innate immune receptors. Cancer Lett. 2019;452:59\u201365.","journal-title":"Cancer Lett"},{"key":"7909_CR26","doi-asserted-by":"publisher","first-page":"103189","DOI":"10.1016\/j.jaut.2024.103189","volume":"145","author":"C Gaudenzi","year":"2024","unstructured":"Gaudenzi C, Schioppa T, Passari M, Zucchi G, Tiberio L, Vahidi Y, et al. Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7\/8 engagement. J Autoimmun. 2024;145:103189.","journal-title":"J Autoimmun"},{"key":"7909_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cpt.2606","volume":"112","author":"L Klopp-Schulze","year":"2022","unstructured":"Klopp-Schulze L, Shaw JV, Dong JQ, Khandelwal A, Vazquez-Mateo C, Goteti K. Applying Modeling and simulations for rational dose selection of novel Toll-like receptor 7\/8 inhibitor Enpatoran for indications of high medical need. Clin Pharmacol Ther. 2022;112:297\u2013306.","journal-title":"Clin Pharmacol Ther"},{"key":"7909_CR28","doi-asserted-by":"crossref","unstructured":"Klopp-Schulze L, Gopalakrishnan S, Yalkinoglu \u00d6, Kuroki Y, Lu H, Goteti K, et al. Asia-inclusive global development of enpatoran: results of an ethno-bridging study, intrinsic\/extrinsic factor assessments and disease trajectory modeling to inform design of a phase II multiregional clinical trial. Clin Pharmacol Ther. 2024.","DOI":"10.1002\/cpt.3216"},{"key":"7909_CR29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP. Psoriasis. Lancet. 2015;386:983\u201394.","journal-title":"Lancet"},{"key":"7909_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20050500","volume":"202","author":"FO Nestle","year":"2005","unstructured":"Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med. 2005;202:135\u201343.","journal-title":"The J Exp Med"},{"key":"7909_CR31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nm1605","volume":"13","author":"C Conrad","year":"2007","unstructured":"Conrad C, Boyman O, Tonel G, Tun-Kyi A, Laggner U, de Fougerolles A, et al. Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med. 2007;13:836\u201342.","journal-title":"Nat Med"},{"key":"7909_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12967-024-05457-4","volume":"22","author":"T Schioppa","year":"2024","unstructured":"Schioppa T, Gaudenzi C, Zucchi G, Piser\u00e0 A, Vahidi Y, Tiberio L, et al. Extracellular vesicles at the crossroad between cancer progression and immunotherapy: focus on dendritic cells. J Transl Med. 2024;22:691.","journal-title":"J Transl Med"},{"key":"7909_CR33","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1046\/j.1523-1747.2002.19515.x","volume":"119","author":"A Wollenberg","year":"2002","unstructured":"Wollenberg A, Wagner M, G\u00fcnther S, Towarowski A, Tuma E, Moderer M, et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol. 2002;119:1096\u2013102.","journal-title":"The J Invest Dermatol"},{"key":"7909_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/08916930903510906","volume":"43","author":"C Albanesi","year":"2010","unstructured":"Albanesi C, Scarponi C, Bosisio D, Sozzani S, Girolomoni G. Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis. Autoimmunity. 2010;43:215\u201319.","journal-title":"Autoimmunity"},{"key":"7909_CR35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature06116","volume":"449","author":"R Lande","year":"2007","unstructured":"Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007;449:564\u201369.","journal-title":"Nature"},{"key":"7909_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/eji.201344277","volume":"45","author":"R Lande","year":"2015","unstructured":"Lande R, Chamilos G, Ganguly D, Demaria O, Frasca L, Durr S, et al. Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA. Eur J Immunol. 2015;45:203\u201313.","journal-title":"Eur J Immunol"},{"key":"7909_CR37","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1084\/jem.20090480","volume":"206","author":"D Ganguly","year":"2009","unstructured":"Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. The J Exp Med. 2009;206:1983\u201394.","journal-title":"The J Exp Med"},{"key":"7909_CR38","doi-asserted-by":"crossref","unstructured":"Sonkoly E, Wei T, Janson PC, S\u00e4\u00e4f A, Lundeberg L, Tengvall-Linder M, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One. 2007;2:e610.","DOI":"10.1371\/journal.pone.0000610"},{"key":"7909_CR39","doi-asserted-by":"crossref","unstructured":"Lerman G, Avivi C, Mardoukh C, Barzilai A, Tessone A, Gradus B, et al. MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS One. 2011;6:e20916.","DOI":"10.1371\/journal.pone.0020916"},{"key":"7909_CR40","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","volume":"15","author":"JQ Chen","year":"2016","unstructured":"Chen JQ, Papp G, Szodoray P, Zeher M. The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun Rev. 2016;15:1171\u201380.","journal-title":"Autoimmun Rev"},{"key":"7909_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12967-024-05030-z","volume":"22","author":"YJ Park","year":"2024","unstructured":"Park YJ, Kim DC, Lee SJ, Kim HS, Pak JY, Kim J, et al. Keratinocyte-derived circulating microRNAs in extracellular vesicles: a novel biomarker of psoriasis severity and potential therapeutic target. J Transl Med. 2024;22:235.","journal-title":"J Transl Med"},{"key":"7909_CR42","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1001\/archderm.140.2.218","volume":"140","author":"G Krueger","year":"2004","unstructured":"Krueger G, Callis K. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis. Arch Dermatol. 2004;140:218\u201325.","journal-title":"Arch Dermatol"},{"key":"7909_CR43","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"A Di Cesare","year":"2009","unstructured":"Di Cesare A, Di Meglio P, Nestle FO. The IL-23\/Th17 axis in the immunopathogenesis of psoriasis. The J Invest Dermatol. 2009;129:1339\u201350.","journal-title":"The J Invest Dermatol"},{"key":"7909_CR44","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/jdv.14451","volume":"31","author":"M Amin","year":"2017","unstructured":"Amin M, Darji K, No DJ, Wu JJ. Review of phase III trial data on IL-23 inhibitors tildrakizumab and guselkumab for psoriasis. J Eur Acad Dermatol Venereol. 2017;31:1627\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7909_CR45","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1186\/s12967-025-06628-7","volume":"23","author":"B Aybey","year":"2025","unstructured":"Aybey B, Brors B, Staub E. Expression signatures with specificity for type I and II IFN response and relevance for autoimmune diseases and cancer. J Transl Med. 2025;23:740.","journal-title":"J Transl Med"},{"key":"7909_CR46","doi-asserted-by":"crossref","unstructured":"Sato Y, Ogawa E, Okuyama R. Role of innate immune cells in psoriasis. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21186604"},{"key":"7909_CR47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1074-7613(01)00197-2","volume":"15","author":"J Trowsdale","year":"2001","unstructured":"Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity. 2001;15:363\u201374.","journal-title":"Immunity"},{"key":"7909_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S1471-4906(00)01802-0","volume":"22","author":"R Barten","year":"2001","unstructured":"Barten R, Torkar M, Haude A, Trowsdale J, Wilson MJ. Divergent and convergent evolution of NK-cell receptors. Trends Immunol. 2001;22:52\u201357.","journal-title":"Trends Immunol"},{"key":"7909_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12967-022-03437-0","volume":"20","author":"J Chu","year":"2022","unstructured":"Chu J, Gao F, Yan M, Zhao S, Yan Z, Shi B, et al. Natural killer cells: a promising immunotherapy for cancer. J Transl Med. 2022;20:240.","journal-title":"J Transl Med"},{"key":"7909_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","volume":"17","author":"CA Biron","year":"1999","unstructured":"Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189\u2013220.","journal-title":"Annu Rev Immunol"},{"key":"7909_CR51","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y","volume":"32","author":"L Moretta","year":"2002","unstructured":"Moretta L, Bottino C, Pende D, Mingari MC, Biassoni R, Moretta A. Human natural killer cells: their origin, receptors and function. Eur J Immunol. 2002;32:1205\u201311.","journal-title":"Eur J Immunol"},{"key":"7909_CR52","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1177\/1753425918800200","volume":"24","author":"JE Beliz\u00e1rio","year":"2018","unstructured":"Beliz\u00e1rio JE, Neyra JM, Set\u00fabal Destro Rodrigues MF. When and how NK cell-induced programmed cell death benefits immunological protection against intracellular pathogen infection. Innate Immun. 2018;24:452\u201365.","journal-title":"Innate Immun"},{"key":"7909_CR53","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.4049\/jimmunol.175.3.1636","volume":"175","author":"OM Hart","year":"2005","unstructured":"Hart OM, Athie-Morales V, O\u2019Connor GM, Gardiner CM. TLR7\/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol. 2005;175:1636\u201342.","journal-title":"J Immunol"},{"key":"7909_CR54","doi-asserted-by":"crossref","unstructured":"Veneziani I, Alicata C, Pelosi A, Landolina N, Ricci B, D\u2019Oria V, et al. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56. J Immunother Cancer. 2022;10.","DOI":"10.1136\/jitc-2021-003385"},{"key":"7909_CR55","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1158\/1078-0432.CCR-11-1625","volume":"18","author":"H Lu","year":"2012","unstructured":"Lu H, Dietsch GN, Matthews MA, Yang Y, Ghanekar S, Inokuma M, et al. VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. Clin Cancer Res. 2012;18:499\u2013509.","journal-title":"Clin Cancer Res"},{"key":"7909_CR56","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1182\/blood-2012-07-441360","volume":"121","author":"S He","year":"2013","unstructured":"He S, Chu J, Wu LC, Mao H, Peng Y, Alvarez-Breckenridge CA, et al. MicroRNAs activate natural killer cells through Toll-like receptor signaling. Blood. 2013;121:4663\u201371.","journal-title":"Blood"},{"key":"7909_CR57","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/intimm\/dxl046","volume":"18","author":"KS Gorski","year":"2006","unstructured":"Gorski KS, Waller EL, Bjornton-Severson J, Hanten JA, Riter CL, Kieper WC, et al. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int Immunol. 2006;18:1115\u201326.","journal-title":"Int Immunol"},{"key":"7909_CR58","doi-asserted-by":"publisher","first-page":"7658","DOI":"10.4049\/jimmunol.178.12.7658","volume":"178","author":"G Alter","year":"2007","unstructured":"Alter G, Suscovich TJ, Teigen N, Meier A, Streeck H, Brander C, et al. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J Immunol. 2007;178:7658\u201366.","journal-title":"J Immunol"},{"key":"7909_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cytogfr.2018.03.008","volume":"42","author":"H Stabile","year":"2018","unstructured":"Stabile H, Fionda C, Santoni A, Gismondi A. Impact of bone marrow-derived signals on NK cell development and functional maturation. Cytokine Growth Factor Rev. 2018;42:13\u201319.","journal-title":"Cytokine Growth Factor Rev"},{"key":"7909_CR60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00403-002-0349-4","volume":"294","author":"AL Cameron","year":"2002","unstructured":"Cameron AL, Kirby B, Fei W, Griffiths CE. Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res. 2002;294:363\u201369.","journal-title":"Arch Dermatol Res"},{"key":"7909_CR61","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/j.1365-2133.2004.05863.x","volume":"150","author":"WH Vissers","year":"2004","unstructured":"Vissers WH, Arndtz CH, Muys L, Van Erp PE, de Jong EM, van de Kerkhof PC. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol. 2004;150:852\u201359.","journal-title":"Br J Dermatol"},{"key":"7909_CR62","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/eji.200535243","volume":"36","author":"C Ottaviani","year":"2006","unstructured":"Ottaviani C, Nasorri F, Bedini C, de Pit\u00e0 O, Girolomoni G, Cavani A. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol. 2006;36:118\u201328.","journal-title":"Eur J Immunol"},{"key":"7909_CR63","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1365-2133.2010.09917.x","volume":"163","author":"RN Cardili","year":"2010","unstructured":"Cardili RN, Alves TG, Freitas JC, Soares CP, Mendes-Junior CT, Soares EG, et al. Expression of human leucocyte antigen-G primarily targets affected skin of patients with psoriasis. Br J Dermatol. 2010;163:769\u201375.","journal-title":"Br J Dermatol"},{"key":"7909_CR64","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fimmu.2012.00258","volume":"3","author":"S Rajagopalan","year":"2012","unstructured":"Rajagopalan S, Long EO. KIR2DL4 (CD158d): an activation receptor for HLA-G. Front Immunol. 2012;3:258.","journal-title":"Front Immunol"},{"key":"7909_CR65","doi-asserted-by":"publisher","first-page":"988962","DOI":"10.3389\/fmed.2022.988962","volume":"9","author":"SA Mostafa","year":"2022","unstructured":"Mostafa SA, Mohammad MHS, Negm WA, Batiha GES, Alotaibi SS, Albogami SM, et al. Circulating microRNA203 and its target genes\u2019 role in psoriasis pathogenesis. Front Med (Lausanne). 2022;9:988962","journal-title":"Front Med (Lausanne)"},{"key":"7909_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri2057","volume":"7","author":"KC Newman","year":"2007","unstructured":"Newman KC, Riley EM. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol. 2007;7:279\u201391.","journal-title":"Nat Rev Immunol"},{"key":"7909_CR67","doi-asserted-by":"publisher","first-page":"1360291","DOI":"10.3389\/fimmu.2024.1360291","volume":"15","author":"L Tiberio","year":"2024","unstructured":"Tiberio L, Laffranchi M, Zucchi G, Salvi V, Schioppa T, Sozzani S, et al. Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer. Front Immunol. 2024;15:1360291.","journal-title":"Front Immunol"},{"key":"7909_CR68","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.imbio.2009.06.016","volume":"214","author":"E Riboldi","year":"2009","unstructured":"Riboldi E, Daniele R, Cassatella MA, Sozzani S, Bosisio D. Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. Immunobiology. 2009;214:868\u201376.","journal-title":"Immunobiology"},{"key":"7909_CR69","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1182\/blood-2010-06-287243","volume":"117","author":"C Costantini","year":"2011","unstructured":"Costantini C, Calzetti F, Perbellini O, Micheletti A, Scarponi C, Lonardi S, et al. Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3. Blood. 2011;117:1677\u201386.","journal-title":"Blood"},{"key":"7909_CR70","doi-asserted-by":"crossref","unstructured":"H\u00e4nsel A, G\u00fcnther C, Ingwersen J, Starke J, Schmitz M, Bachmann M, et al. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17\/TH1 T-cell responses. J Allergy Clin Immunol. 2011;127:787\u2013794.e781\u2013789.","DOI":"10.1016\/j.jaci.2010.12.009"},{"key":"7909_CR71","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.4049\/jimmunol.162.9.5238","volume":"162","author":"KB Nguyen","year":"1999","unstructured":"Nguyen KB, Biron CA. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production. J Immunol. 1999;162:5238\u201346.","journal-title":"J Immunol"},{"key":"7909_CR72","doi-asserted-by":"publisher","first-page":"6873","DOI":"10.4049\/jimmunol.173.11.6873","volume":"173","author":"HP Rau\u00e9","year":"2004","unstructured":"Rau\u00e9 HP, Brien JD, Hammarlund E, Slifka MK. Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J Immunol. 2004;173:6873\u201381.","journal-title":"J Immunol"},{"key":"7909_CR73","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.4049\/jimmunol.166.2.1097","volume":"166","author":"G Lertmemongkolchai","year":"2001","unstructured":"Lertmemongkolchai G, Cai G, Hunter CA, Bancroft GJ. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol. 2001;166:1097\u2013105.","journal-title":"J Immunol"},{"key":"7909_CR74","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/eji.1830260736","volume":"26","author":"MJ Micallef","year":"1996","unstructured":"Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol. 1996;26:1647\u201351.","journal-title":"Eur J Immunol"},{"key":"7909_CR75","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.4049\/jimmunol.169.10.5827","volume":"169","author":"GC Pien","year":"2002","unstructured":"Pien GC, Nguyen KB, Malmgaard L, Satoskar AR, Biron CA. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J Immunol. 2002;169:5827\u201337.","journal-title":"J Immunol"},{"key":"7909_CR76","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.4049\/jimmunol.160.12.6032","volume":"160","author":"T Sareneva","year":"1998","unstructured":"Sareneva T, Matikainen S, Kurimoto M, Julkunen I. Influenza a virus-induced IFN-alpha\/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol. 1998;160:6032\u201338.","journal-title":"J Immunol"},{"key":"7909_CR77","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.1073\/pnas.1203543109","volume":"109","author":"BE Freeman","year":"2012","unstructured":"Freeman BE, Hammarlund E, Rau\u00e9 HP, Slifka MK. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci USA. 2012;109:9971\u201376.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7909_CR78","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuron.2014.02.011","volume":"82","author":"CK Park","year":"2014","unstructured":"Park CK, Xu ZZ, Berta T, Han Q, Chen G, Liu XJ, et al. Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron. 2014;82:47\u201354.","journal-title":"Neuron"},{"key":"7909_CR79","doi-asserted-by":"crossref","unstructured":"Salama A, Fichou N, Allard M, Dubreil L, De Beaurepaire L, Viel A, et al. MicroRNA-29b modulates innate and antigen-specific immune responses in mouse models of autoimmunity. PLoS One. 2014;9:e106153.","DOI":"10.1371\/journal.pone.0106153"},{"key":"7909_CR80","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.expneurol.2015.04.011","volume":"269","author":"HY Liu","year":"2015","unstructured":"Liu HY, Huang CM, Hung YF, Hsueh YP. The microRNAs Let7c and miR21 are recognized by neuronal Toll-like receptor 7 to restrict dendritic growth of neurons. Exp Neurol. 2015;269:202\u201312.","journal-title":"Exp Neurol"},{"key":"7909_CR81","doi-asserted-by":"crossref","unstructured":"Yelamanchili SV, Lamberty BG, Rennard DA, Morsey BM, Hochfelder CG, Meays BM, et al. Correction: MiR-21 in extracellular vesicles leads to neurotoxicity via TLR7 signaling in SIV neurological disease. PLoS Pathog. 2015;11:e1005131.","DOI":"10.1371\/journal.ppat.1005131"},{"key":"7909_CR82","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/art.39544","volume":"68","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Chen Z, Essani AB, Elshabrawy HA, Volin MV, Volkov S, et al. Identification of a novel Toll-like receptor 7 endogenous ligand in rheumatoid arthritis synovial fluid that can provoke arthritic joint inflammation. Arthritis Rheumatol. 2016;68:1099\u2013110.","journal-title":"Arthritis Rheumatol"},{"key":"7909_CR83","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12974-017-0799-4","volume":"14","author":"LG Coleman","year":"2017","unstructured":"Coleman LG, Zou J, Crews FT. Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7. J Neuroinflammation. 2017;14:22.","journal-title":"J Neuroinflammation"},{"key":"7909_CR84","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.4049\/jimmunol.1700730","volume":"199","author":"Y Feng","year":"2017","unstructured":"Feng Y, Zou L, Yan D, Chen H, Xu G, Jian W, et al. Extracellular MicroRNAs induce potent innate immune responses via TLR7\/MyD88-dependent mechanisms. J Immunol. 2017;199:2106\u201317.","journal-title":"J Immunol"},{"key":"7909_CR85","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.4049\/jimmunol.1601778","volume":"198","author":"P Ranganathan","year":"2017","unstructured":"Ranganathan P, Ngankeu A, Zitzer NC, Leoncini P, Yu X, Casadei L, et al. Serum miR-29a is upregulated in acute graft-versus-Host disease and activates dendritic cells through TLR Binding. J Immunol. 2017;198:2500\u201312.","journal-title":"J Immunol"},{"key":"7909_CR86","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.clim.2016.12.005","volume":"176","author":"NA Young","year":"2017","unstructured":"Young NA, Valiente GR, Hampton JM, Wu LC, Burd CJ, Willis WL, et al. Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus. Clin Immunol. 2017;176:12\u201322.","journal-title":"Clin Immunol"},{"key":"7909_CR87","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.4049\/jimmunol.1801008","volume":"201","author":"J Xu","year":"2018","unstructured":"Xu J, Feng Y, Jeyaram A, Jay SM, Zou L, Chao W. Circulating plasma extracellular vesicles from septic mice induce inflammation via MicroRNA- and TLR7-dependent mechanisms. J Immunol. 2018;201:3392\u2013400.","journal-title":"J Immunol"},{"key":"7909_CR88","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1073\/pnas.1814139116","volume":"116","author":"Y Wang","year":"2019","unstructured":"Wang Y, Liang H, Jin F, Yan X, Xu G, Hu H, et al. Injured liver-released miRNA-122 elicits acute pulmonary inflammation via activating alveolar macrophage TLR7 signaling pathway. Proc Natl Acad Sci USA. 2019;116:6162\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7909_CR89","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2004.06.007","volume":"21","author":"A Krug","year":"2004","unstructured":"Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity. 2004;21:107\u201319.","journal-title":"Immunity"},{"key":"7909_CR90","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1099\/vir.0.80105-0","volume":"85","author":"J Sir\u00e9n","year":"2004","unstructured":"Sir\u00e9n J, Sareneva T, Pirhonen J, Strengell M, Veckman V, Julkunen I, et al. Cytokine and contact-dependent activation of natural killer cells by influenza a or Sendai virus-infected macrophages. J Gen Virol. 2004;85:2357\u201364.","journal-title":"J Gen Virol"},{"key":"7909_CR91","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4049\/jimmunol.174.2.727","volume":"174","author":"F Gerosa","year":"2005","unstructured":"Gerosa F, Gobbi A, Zorzi P, Burg S, Briere F, Carra G, et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol. 2005;174:727\u201334.","journal-title":"J Immunol"},{"key":"7909_CR92","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ni1244","volume":"6","author":"CE Andoniou","year":"2005","unstructured":"Andoniou CE, van Dommelen SL, Voigt V, Andrews DM, Brizard G, Asselin-Paturel C, et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol. 2005;6:1011\u201319.","journal-title":"Nat Immunol"},{"key":"7909_CR93","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1084\/jem.20080129","volume":"206","author":"C Albanesi","year":"2009","unstructured":"Albanesi C, Scarponi C, Pallotta S, Daniele R, Bosisio D, Madonna S, et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. The J Exp Med. 2009;206:249\u201358.","journal-title":"The J Exp Med"},{"key":"7909_CR94","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1038\/s41598-019-41655-7","volume":"9","author":"Y Wang","year":"2019","unstructured":"Wang Y, Edelmayer R, Wetter J, Salte K, Gauvin D, Leys L, et al. Monocytes\/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation. Sci Rep. 2019;9:5310.","journal-title":"Sci Rep"},{"key":"7909_CR95","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4049\/jimmunol.1501558","volume":"196","author":"KW Tosh","year":"2016","unstructured":"Tosh KW, Mittereder L, Bonne-Annee S, Hieny S, Nutman TB, Singer SM, et al. The IL-12 response of primary human dendritic cells and monocytes to toxoplasma gondii is stimulated by phagocytosis of live parasites rather than Host cell invasion. J Immunol. 2016;196:345\u201356.","journal-title":"J Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07909-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07909-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07909-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T12:02:26Z","timestamp":1778328146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07909-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7909"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07909-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"478"}}